Application 021202

Type
NDA
Sponsor
EMD SERONO INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001GLUCOPHAGE XRMETFORMIN HYDROCHLORIDETABLET, EXTENDED RELEASE;ORAL500MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
004GLUCOPHAGE XRMETFORMIN HYDROCHLORIDETABLET, EXTENDED RELEASE;ORAL750MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0087-6063GLUCOPHAGEMETFORMIN HYDROCHLORIDEBristol-Myers Squibb CompanyNDACurrent
0087-6063GLUCOPHAGEMETFORMIN HYDROCHLORIDEBristol-Myers Squibb CompanyNDACurrent
0087-6064GLUCOPHAGEMETFORMIN HYDROCHLORIDEBristol-Myers Squibb CompanyNDACurrent
0087-6064GLUCOPHAGEMETFORMIN HYDROCHLORIDEBristol-Myers Squibb CompanyNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
54396SUPPL2018-05-31
54382SUPPL2018-05-31
47946SUPPL2017-04-12
47945SUPPL2017-04-12
47936SUPPL2017-04-11
47935SUPPL2017-04-11
14628SUPPL2008-08-29
27051SUPPL2008-08-28
36336SUPPL2006-11-06
4628SUPPL2006-11-06
42018ORIG2004-06-04
4627SUPPL2004-03-24
4626SUPPL2004-03-24
4625SUPPL2003-04-18
14627SUPPL2003-04-17
4624SUPPL2002-01-08
4623SUPPL2001-04-19
14626ORIG2000-10-13
4622ORIG2000-10-13